These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 30572156)

  • 21. Disease-directed design of biodegradable polymers: Reactive oxygen species and pH-responsive micellar nanoparticles for anticancer drug delivery.
    Leong J; Chin W; Ke X; Gao S; Kong H; Hedrick JL; Yang YY
    Nanomedicine; 2018 Nov; 14(8):2666-2677. PubMed ID: 30017961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells.
    Tambe P; Kumar P; Paknikar KM; Gajbhiye V
    Int J Nanomedicine; 2018; 13():7669-7680. PubMed ID: 30538451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
    Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
    Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    He Y; Su Z; Xue L; Xu H; Zhang C
    J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel pH-Responsive Iron Oxide Core-Shell Magnetic Mesoporous Silica Nanoparticle (M-MSN) System Encapsulating Doxorubicin (DOX) and Glucose Oxidase (Gox) for Pancreatic Cancer Treatment.
    Qi G; Shi G; Wang S; Hu H; Zhang Z; Yin Q; Li Z; Hao L
    Int J Nanomedicine; 2023; 18():7133-7147. PubMed ID: 38054080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In situ biodegradable crosslinking of cationic oligomer coating on mesoporous silica nanoparticles for drug delivery.
    Wang Y; Wang J; Yang Y; Sun Y; Yuan Y; Li Y; Liu C
    Colloids Surf B Biointerfaces; 2017 May; 153():272-279. PubMed ID: 28279933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells.
    Tiburcius S; Krishnan K; Jose L; Patel V; Ghosh A; Sathish CI; Weidenhofer J; Yang JH; Verrills NM; Karakoti A; Vinu A
    Nanoscale; 2022 May; 14(18):6830-6845. PubMed ID: 35441642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sterically Stabilised Polymeric Mesoporous Silica Nanoparticles Improve Doxorubicin Efficiency: Tailored Cancer Therapy.
    Moodley T; Singh M
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32046364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells.
    Zhou S; Wu D; Yin X; Jin X; Zhang X; Zheng S; Wang C; Liu Y
    J Exp Clin Cancer Res; 2017 Feb; 36(1):24. PubMed ID: 28166836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
    Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
    J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. pH-sensitive poly(glutamic acid) grafted mesoporous silica nanoparticles for drug delivery.
    Zheng J; Tian X; Sun Y; Lu D; Yang W
    Int J Pharm; 2013 Jun; 450(1-2):296-303. PubMed ID: 23598077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. pH-responsive controlled release of mesoporous silica nanoparticles capped with Schiff base copolymer gatekeepers: Experiment and molecular dynamics simulation.
    Peng S; Yuan X; Lin W; Cai C; Zhang L
    Colloids Surf B Biointerfaces; 2019 Apr; 176():394-403. PubMed ID: 30660963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced Efficacy against Drug-Resistant Tumors Enabled by Redox-Responsive Mesoporous-Silica-Nanoparticle-Supported Lipid Bilayers as Targeted Delivery Vehicles.
    Yang S; Zhang B; Zhao X; Zhang M; Zhang M; Cui L; Zhang L
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amino-functionalized mesoporous silica nanoparticles as efficient carriers for anticancer drug delivery.
    He Y; Luo L; Liang S; Long M; Xu H
    J Biomater Appl; 2017 Oct; 32(4):524-532. PubMed ID: 28776488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxorubicin-Loaded Carbon Dots Lipid-Coated Calcium Phosphate Nanoparticles for Visual Targeted Delivery and Therapy of Tumor.
    Zhang J; Zhang H; Jiang J; Cui N; Xue X; Wang T; Wang X; He Y; Wang D
    Int J Nanomedicine; 2020; 15():433-444. PubMed ID: 32021189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of carboxyl modified chiral mesoporous silica nanoparticles in delivering doxorubicin hydrochloride in vitro: pH-response controlled release, enhanced drug cellular uptake and cytotoxicity.
    Li J; Du X; Zheng N; Xu L; Xu J; Li S
    Colloids Surf B Biointerfaces; 2016 May; 141():374-381. PubMed ID: 26878288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.
    Li Z; Zhang L; Tang C; Yin C
    Pharm Res; 2017 Dec; 34(12):2829-2841. PubMed ID: 28948461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A chitosan/mesoporous silica nanoparticle-based anticancer drug delivery system with a "tumor-triggered targeting" property.
    Liao T; Liu C; Ren J; Chen H; Kuang Y; Jiang B; Chen J; Sun Z; Li C
    Int J Biol Macromol; 2021 Jul; 183():2017-2029. PubMed ID: 34097958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel high drug loading mussel-inspired polydopamine hybrid nanoparticle as a pH-sensitive vehicle for drug delivery.
    Hou J; Guo C; Shi Y; Liu E; Dong W; Yu B; Liu S; Gong J
    Int J Pharm; 2017 Nov; 533(1):73-83. PubMed ID: 28943209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.